Shares of Sun Pharmaceutical Industries Ltd. 524715 rallied 3.12% to 1,746.50 Indian rupees Thursday, on what proved to be an all-around grim trading session for the stock market, with the BSE SENSEX ...

Sun Pharmaceutical Industries Ltd. closed 13.60% short of its 52-week high of 1,960.20 rupees, which the company achieved on ...

New Delhi: Sun Pharmaceutical Industries reported a 15 percent on-year increase in consolidated net profit, reaching Rs 2,903 crore for the December quarter, driven by strong sales across geographies.

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Brokerages remained divided on Sun Pharmaceuticals after it delivered a steady and in line third quarter earnings performance for the financial year 2024-25 (Q3FY25), with some bullish on specialty ...

It declared an interim dividend of Rs 5 per share. Sun Pharmaceuticals Industries: The drug major reported a 15 per cent YoY growth in its net profit at Rs 2,903.4 crore, while revenue inched up ...

Sun Pharma delivered a strong Q3 performance, surpassing Street expectations. However, concerns over the uncertain launch timeline of its hair loss drug Leqselvi and a cut in R&D spending have led ...

Sun Pharma Q3 Results: Sun Pharmaceutical Industries on Friday said its consolidated net profit increased 15 per cent on-year to Rs 2,903 crore in the December quarter, riding on robust sales across ...

AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of the budget announcements. Stocks including ONGC, Sun Pharma, IndusInd Bank, Nestle, Tata Power, Waaree Energies, IRB Infra ...

Sun Pharma's Q3FY25 net profit rose 15% YoY to ₹2,903 crore, driven by strong domestic and global specialty sales. Revenue grew 10.5%, while EBITDA surged 15.3% with improved margins. The company ...

Sun Pharma Q3 Results: The company has also declared an interim dividend of Rs 10.5 per share for the financial year 2024-25. Sun Pharma on Friday reported 15% year-on-year (YoY) to Rs 2,903 crore in ...

Shares of Sun Pharma Ltd., India's largest drugmaker gained as much as 1.3% after declining as much as 2% when it reported its December quarter results. The stock gained despite its US formulation ...